Text Size
Trial record 9 of 119 for:    osteonecrosis
Previous Study | Return to List | Next Study

Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip

This study has been completed.
Sponsor:
Information provided by:
Orthopedic Hospital Vienna Speising
ClinicalTrials.gov Identifier:
NCT01133938
First received: May 28, 2010
Last updated: June 1, 2010
Last verified: May 2010
History of Changes
  Purpose

Several risk factors for the development of osteonecrosis of the femoral head following treatment of developmental dislocated hip have been reported. The need for further research with a large-enough sample size including statistical adjustment of confounders was demanded. The purpose of the present study was to find reliable predictors of osteonecrosis in patients managed for developmental dislocation of the hip and to evaluate if delayed treatment increased the risk of residual acetabular dysplasia requiring secondary surgeries.


Condition
Predictors of Osteonecrosis of the Femoral Head After Treatment of the Dislocated Hip

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip. A Comparison of Early Open Reduction Versus Late Open Reduction With Combined Pemberton and Femoral Osteotomies

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Orthopedic Hospital Vienna Speising:

Primary Outcome Measures:
  • Osteonecrosis of the femoral head

Secondary Outcome Measures:
  • Secondary reconstructive procedures due to residual acetabular dysplasia

Enrollment: 79
Study Start Date: January 2009
Study Completion Date: May 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Closed reduction < 12 months of age
Open reduction < 12 months of age
Open reduction with concomitant osteotomies > 12 months fo age

  Eligibility

Ages Eligible for Study:   1 Month to 15 Years
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

Consecutive series of patients hospitalized because of developmental dislocated hip between 1198 and February 2007

Criteria

Inclusion Criteria:

  • Follow-up > 3 years

Exclusion Criteria:

  • teratological hip dislocation
  • neuromuscular disease
  • previous open reduction at another medical institution
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01133938

Locations
Austria
Orthopedic Hospital Vienna Speising
Vienna, Austria, 1130
Sponsors and Collaborators
Orthopedic Hospital Vienna Speising
  More Information

No publications provided

Responsible Party: Orthopedic Hospital Vienna Speising
ClinicalTrials.gov Identifier: NCT01133938     History of Changes
Other Study ID Numbers: OR-27052010
Study First Received: May 28, 2010
Last Updated: June 1, 2010
Health Authority: Austria: Institutional Review Board

Additional relevant MeSH terms:
Hip Dislocation
Osteonecrosis
Dislocations
Wounds and Injuries
Hip Injuries
 Bone Diseases
Musculoskeletal Diseases
Necrosis
Pathologic Processes

ClinicalTrials.gov processed this record on June 18, 2013